Cambridge Innovation Capital

We are delighted to share our latest Impact and ESG Report https://lnkd.in/eip6eRJv, highlighting our work and significant progress over the last four years. We are committed to ensuring that the innovations at the core of our founders’ businesses have the potential to positively influence people’s lives. By investing in solutions tackling global challenges, we aim to lead innovation that not only drives economic success but also contributes to a more sustainable and equitable future. Northern Gritstone, Oxford Science Enterprises, Jones and Palmer, City of London Corporation, British Business Bank, Innovate UK, Global Corporate Venturing, Taylor Wessing, PwC, Pragmatic Semiconductor, Cambridge GaN Devices Ltd, ESG_VC, Sam Sturge, Riverlane #impact #ESG #CreatingaBetterFuture https://lnkd.in/e-sYeU4B

Thank you all so much for your enthusiastic support for Innovate Cambridge and The Glasshouse in 2024 Some dates for your brand new 2025 diary: The Glasshouse will close on the 20th December and reopen for the new year on 6th January at 8am. We look forward to welcoming members and visitors back to the space then. 8th January - Members New Years Networking Breakfast 8:30am-10:30am 25th January - Open House: Every Month the Glasshouse will be open to visitors from the wider Cambridge community. You are welcome to come and use the space, have a coffee and meet other interested in innovation between 1-4pm. Cambridge Enterprise Cambridge Innovation Capital

A huge congratulations to our co-founder Wolfram Pernice for being awarded the prestigious Leibniz prize (Germany's most important research award that honours outstanding scientists and academics) for his incredible work on Integrated Photonics! We are very proud of his achievements and the world-leading research he is doing to pioneer new developments in Photonics. Read the full University of Heidelberg release here: https://lnkd.in/e6Uf_mpR

We are excited to announce that CGD's 650 V ICeGaN® P2 Series has won Best Power Semiconductor of the Year by EE Awards Asia! 🏆 CGD's 650 V ICeGaN® P2 Series ICs are uniquely designed for high-power applications, like data centres, motor drives and EV chargers, with ease of use, gate reliability and efficiency in mind. Powered by our innovative ICeGaN® technology, they can seamlessly interface with Si MOSFET, SiC and IGBT gate drivers. Besides, the P2 Series offer thermally-enhanced packages featuring bottom-side cooling and dual-side cooling that improve heat dissipation and increase efficiency. Learn more about the products here 👉 https://lnkd.in/gcfqyipt A huge thank you to EE Times Asia for this honor and to our incredible team for their continuous commitment to innovation. Together, we’re shaping the future of clean, sustainable tech. #GreenTech #galliumnitride #Sustainability #Innovation #Efficiency #PowerSemiconductors #CleanTech

A new generation of Cambridge founders and business leaders are pledging a percentage of their current or future personal wealth to address the city’s growing inequality.  Having benefited from the success and reputation of the famed Cambridge cluster, these next-gen entrepreneurs are paying it forward so that the city’s innovation and success benefits the wider Cambridge community.  Through The Cambridge Pledge, the entrepreneurs are making a donation, or pledging at least 5% of their future wealth, to create a multimillion-pound fund. This will then be used to tackle some of the region’s most critical issues, including youth education, homes for children in care, homelessness and health disparities. Find out more about why Lucy Jung, Marcel Gehrung, PhD, Tony Kouzarides, and others are getting involved https://lnkd.in/eadUEPHf. And if you’re interested in finding out more - whether you’d like to discuss pledging or donating, to explore being a trustee, or just to say hello – please get in touch https://lnkd.in/ecfQahGy. Sara Allen, Cambridge City Council, Innovate Cambridge, Kathryn Chapman, Daniel Zeichner, Councillor Mike Davey, Edward Benthall, Clare Sutcliffe MBE, Cambridge Innovation Capital, Mishcon de Reya LLP, Jemma Little, Faye Holland

✨ We are hiring! Join our Team at Innovate Cambridge! ✨ Do you want to be at the heart of Cambridge’s innovation and healthcare community, working alongside leaders shaping the future? If so, we have a role for you! Innovate Cambridge’s brand-new community space is now open, and we’re hiring for two positions. Join Innovate Cambridge and Cambridge University Health Partners as our Administrative Assistant/Personal Assistant and make a real impact by supporting two organisations driving world-class innovation and healthcare excellence. Or if you love creating exceptional experiences and thrive on being the first point of contact for an exciting, forward-thinking organization,  apply for the Innovate Cambridge Events and Front-of-House Co-ordinator role. Administrative Assistant/Personal Assistant 💻 As a key member of our team, you’ll juggle a variety of responsibilities, including coordinating meetings, managing calendars, and arranging travel. You will provide essential support for events and office tasks. Every day will be different, so adaptability, attention to detail, and a proactive approach are essential! Events and Front-of-House Co-ordinator 🎉 You’ll be at the heart of our community space, greeting members and visitors, coordinating inspiring events, managing social media, and ensuring the space runs seamlessly. One day, you’ll be hosting a networking event; the next, crafting a social media post to promote our latest workshop. You’ll also maintain a welcoming, organised environment and keep our members connected and engaged. If you’re excited about making a difference in a dynamic, collaborative environment, apply today by sending your CV and cover letter to admin@innovatecambridge.co.uk. Find out more here: https://lnkd.in/eQfV8-5J https://lnkd.in/ehdNazQf Kathryn Chapman Clare Sutcliffe MBE Kristin Anne Rutter Araminta Ledger Cambridge Innovation Capital Cambridge Enterprise Cambridge University Health Partners Cambridge Biomedical Campus

Welcome to the latest edition of CIC news! Highlights include: - New investments in Nuclera, a biotechnology company accelerating protein expression and purification workflows, and Forefront RF, a fabless semiconductor company poised to revolutionise mobile device designs in the growing smartphone and wearables markets, plus further investment in Epitopea - Our 2024 Impact and ESG report - The highlights video from our collaborative investor event at Mansion House - CMR Surgical Versius robot’s FDA marketing authorisation - Microbiotica ’s international Phase 1b trial - Bicycle Therapeutics first human imaging data - Carrick Therapeutics Phase 1 Clinical Trial Thank you to all our portfolio companies, investors and friends for the tremendous support this year 🚀🚀🚀 Northern Gritstone Oxford Science Enterprises Jones and Palmer City of London Corporation British Business Bank Innovate UK Global Corporate Venturing Taylor Wessing PwC Pragmatic Semiconductor Cambridge GaN Devices Ltd ESG_VC Sam Sturge Riverlane #innovation #impact #ukventure https://lnkd.in/gYB-piBY

Always inspired by and grateful for the incredible #womeninbiotech network. BioIndustry Association (BIA) aspiring in 2025 to delve deeper into quant and qual research on female leadership in the sector. 👀this space. Thankyou to Kate Barclay and Anne Horgan (nee Nguyen) for the brainstorm. To the indomitable Claire Thompson for chairing, our truly inspirational #female #ceos Susan Hill Mestag Therapeutics and Bakul Gupta, PhD and to Dr Susanne Coles Innovate UK for the candid explanation of the opportunities and challenges. To Samantha Care for delivering another amazing event. Great to see you Kat Arney Veronique Bouchet Susan Conroy PhD Ming Ewe Sheila Johnson Christelle Kerouedan, PhD Anji Miller Ph.D CLP RTTP Claudia Prevosto Annelise Soulier Cristina Stanciu. Good to connect Duygu Yilmaz Laura Hanooman-Asbjornsen Angela Glen Lily Kutena Abigail Little Rossie Mayhew Michelle Myers Sarah Nedjai Noelia Sainz Pastor. With special thanks for the ongoing steadfast support Nara Daubeney PhD Michele Seymour Nicole Jadeja Eleanor Root (née Reid) Sally Shorthose Bird & Bird And to special guests yesterday from SwedenBIO Jessica Martinsson Maja Neiman it's great to share😊 Looking forward to seeing what 2025 will bring for #womeninbiotech

✨New Application Note to view!📄 Our Breakthrough With the eProtein Discovery System, we've conquered the challenges of expressing full-length transcription factor L - nicknamed TF L, a notoriously difficult to express protein with DNA binding (homeodomain) and LIM Domains and intrinsically disordered regions. By strategically employing solubility tags and optimizing cell-free blends, we've unlocked the secret to producing abundant soluble TF L protein. A Testament to Success We've taken this success a step further by validating the DNA binding function of purified TF L protein. This groundbreaking achievement not only addresses the long-standing limitations in TF L research but also paves the way for innovative therapeutic development. A New Era of Protein Science The eProtein Discovery System is more than just a tool; it's a game-changer. By empowering researchers to efficiently produce complex proteins, we're accelerating scientific discovery and bringing us closer to a future where protein-based therapies are a reality. 📰 Download now https://eprote.in/2lZkkwud #proteinaccess #transcriptionfactors #proteinexpression #proteinscience #proteinengineering #drugdiscovery #biotech

🌟 We are thrilled to be named 'One to Watch' by Sifted in their Biotech 2024 article. This recognition is especially significant as biotech continues to be a leading sector in Europe, attracting substantial investment and demonstrating strong market performance 📈 . This underscores our potential and commitment to advancing impactful therapies for patients 🎯 . We are excited about the opportunities ahead in 2025! Find the full briefing here: https://lnkd.in/e4ykBkCV #biotech #leadership #growth #ophthalmology #genetherapy #complementbiology #seriesA #watch #biotechnology #investment